Morningstar Rating
Stock XNAS Rating as of
$10.39 −0.34(3.17%)
View Full ChartAs of Delayed Price Closed
Company Report
Company Report
Walgreens' Recovery Looks Uncertain as Retail Continues to Suffer and More Store Closures Underway
Keonhee Kim
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the United States, with over 8,500 locations. Nearly three fourths of Americans live within five miles of a Walgreens location. The company operates in three segments: US retail pharmacy, international, and US healthcare.
Price vs Fair Value
Price vs Fair Value
WBA is trading at a 32% premium.
Price
$10.73
Fair Value
$71.00
Uncertainty
Very High
- 1-Star Price
- $15.88
- 5-Star Price
- $47.80
- Economic Moat
- Zmf
- Capital Allocation
- Pjrq
Bulls Say, Bears Say
Bulls Say, Bears Say
Bulls
Walgreens is one of the largest domestic retail pharmacy chains, with around 8,800 US locations. Over three fourths of Americans live within five miles of a Walgreens location.
Bears
The confluence of reimbursem*nt pricing pressure in the retail pharmacy and tough general retail store conditions has diminished profitability and ROICs.
News
News
- WALGREENS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Walgreens Boots Alliance, Inc. - WBA
- Walgreens Boots Alliance, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before September 10, 2024 to Discuss Your Rights – WBA
- DEADLINE ALERT for ICU, MDB, CVS, and WBA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
- WBA Investors Have Opportunity to Lead Walgreens Boots Alliance, Inc. Securities Fraud Lawsuit
- WBA Investors Have Opportunity to Lead Walgreens Boots Alliance, Inc. Securities Fraud Lawsuit with the Schall Law Firm
- Walgreens Boots Alliance, Inc. Sued for Securities Law Violations - Contact The Rosen Law Firm Before September 10, 2024 to Discuss Your Rights - WBA
Trading Information
Trading Information
- Previous Close Price
- $10.73
- Day Range
$10.30–10.69
- 52-Week Range
$10.19–27.05
- Bid/Ask
- $10.40/$10.41
- Market Cap
- $8.97 Bil
- Volume/Avg
- 15.8 Mil/19.2 Mil
Key Statistics
Key Statistics
- Price/Earnings (Normalized)
- 3.30
- Price/Sales
- 0.06
- Dividend Yield (Trailing)
- 11.84%
- Dividend Yield (Forward)
- 9.62%
- Total Yield
- 12.61%
Company Profile
Company Profile
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,500 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Stock Style Box
- Mid Value
- Total Number of Employees
- 331,000
Competitors
Competitors
- Dollar General Corp DG
- Walmart Inc WMT
- CVS Health Corp CVS
Valuation
Valuation
| Metric | WBA | DG | WMT |
|---|---|---|---|
Price/Earnings (Normalized) | 3.30 | 18.01 | 32.41 |
Price/Book Value | 0.66 | 3.88 | 7.17 |
Price/Sales | 0.06 | 0.69 | 0.92 |
Price/Cash Flow | 5.93 | 10.63 | 17.37 |
Price/Earnings
WBA
DG
WMT
Financial Strength
Financial Strength
| Metric | WBA | DG | WMT |
|---|---|---|---|
Quick Ratio | 0.27 | 0.11 | 0.19 |
Current Ratio | 0.65 | 1.22 | 0.80 |
Interest Coverage | −25.87 | 7.12 | 10.38 |
Quick Ratio
WBA
DG
WMT
Profitability
Profitability
| Metric | WBA | DG | WMT |
|---|---|---|---|
Return on Assets (Normalized) | 2.96% | 5.07% | 7.77% |
Return on Equity (Normalized) | 15.55% | 23.87% | 24.81% |
Return on Invested Capital (Normalized) | 5.58% | 7.31% | 14.14% |
Return on Assets
WBA
DG
WMT
Pharmaceutical Retailers Industry Comparables
Pharmaceutical Retailers Industry Comparables
| 1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Raia Drogasil SA ADR RADLY | — | Pxddpf | $9.0 Bil | |||
| JD Health International Inc ADR JDHIY | — | Pkrbl | $8.8 Bil | |||
| JD Health International Inc JDHIF | — | Syrjp | $8.8 Bil | |||
| Alibaba Health Information Technology Ltd ALBHF | — | Snjhrn | $6.2 Bil | |||
| Alibaba Health Information Technology Ltd ADR ALBBY | — | Dtntwvn | $6.2 Bil | |||
| Clicks Group Ltd ADR CLCGY | — | Qhpg | $4.8 Bil | |||
| COSMOS Pharmaceutical Corp CSMYF | — | Djvgjc | $3.8 Bil | |||
| Tsuruha Holdings Inc TSUSF | — | Fkqkj | $2.9 Bil | |||
| Redcare Pharmacy NV SHPPF | — | Grqdm | $2.7 Bil |
Sponsor Center
Site Index
- Our Signature Methodologies
- Morningstar Investment Conference
What We Do
- About Us
- Careers
- Corporate Sustainability
- Newsroom
- Investor Relations
Company
- Advertising Opportunities
- Feedback
- Reprints
- Global Contacts
- Affiliate Program
Get Help
United States
© Copyright 2024 Morningstar, Inc. All rights reserved.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.
- Terms and Conditions
- Privacy Center
- Disclosures
- Member User Agreement
- Corrections
- Do Not Sell or Share My Personal Information
- Accessibility
